![](/img/cover-not-exists.png)
Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK
Johansson, Erin Colleen, Hartz, Susanne, Kiri, Sandeep Himatlal, Kumar, Gayathri, Svedbom, AxelLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1474747
Date:
June, 2018
File:
PDF, 1.58 MB
english, 2018